Quantcast

Latest Atheroma Stories

2009-05-01 07:10:00

Data Presented at American Heart Association ATVB Conference Shows Reduction in Non-Calcified Plaque Volume and Fewer New Plaque Lesions in Treated Patients WASHINGTON and SAN FRANCISCO, May 1 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP) today announced the results of a sub-study of patients in its acute coronary syndrome (ACS) Phase 2 trial who received serial 64 slice multidetector computed tomography (MDCT) scans before and after six months of treatment with its lead...

2009-04-30 12:21:19

German researchers identified 17 protein biomarkers linked to coronary artery disease, which may result in a urine test to screen for heart disease. Clinicians now diagnose the disease using coronary angiogrography -- an X-ray examination of the blood vessels or heart chambers. It requires the insertion of a small tube into a blood vessel and threading it to the coronary arteries. Dr. Constantin von zur Muehlen of the University Hospital Freiburg in Freiburg, Germany, said the biomarkers...

2009-04-30 12:03:17

Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.Coronary angiography, an X-ray examination of the blood vessels or chambers of the heart, is the traditional way to diagnose atherosclerosis. To perform this...

2009-03-31 07:30:00

Data from ACS Phase 2 MDCT Sub-study to be Released Concurrent with AHA Presentation SAN FRANCISCO, March 31 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that an abstract on the Company's Phase 2 clinical trial of VIA-2291 has been accepted for a poster presentation at the American Heart Association Arteriosclerosis, Thrombosis and...

2009-02-25 07:30:00

SAN FRANCISCO, Feb. 25 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced the issuance of United States Patent No. 7,495,024 entitled "Phenylalkyl N-Hydroxyureas for Combating Atherosclerotic Plaque", covering the use of VIA's lead compound, VIA-2291, for the treatment of atherosclerosis. This patent is also pending in other major markets...

2009-02-17 08:30:00

New procedure rooms offer faster and more accurate diagnosis and treatment. LANGHORNE, Pa., Feb. 17 /PRNewswire/ -- St. Mary Medical Center today announces the completion of its state-of-the-art procedure rooms in a completely new cardiovascular catheterization suite. Now located on the second level of the Outpatient Care Facility, the newly constructed area will open with three fully functional state-of-the-art catheterization labs (cath labs) and 14 patient preparation and recovery rooms....

2009-01-26 06:00:00

BOSTON, Jan. 26 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced today that the United States Patent and Trademark Office issued U.S. Patent No. 7,438,891, covering methods of imaging cardiovascular plaque formation using F18 labeled 2-fluorodeoxy-D-glucose (FDG). This patent, exclusively licensed from the Massachusetts General Hospital, provides FluoroPharma with additional patent claims...

2009-01-22 10:16:35

Current research suggests that inflammation increases the risk of plaque rupture in atherosclerosis. The related report by Ovchinnikova et al, "T cell activation leads to reduced collagen maturation in atherosclerotic plaques of ApoE-deficient- mice," appears in the February 2009 issue of The American Journal of Pathology. Atherosclerosis is a disease of arterial blood vessels where fats, cholesterol, blood cells, and fibers form hardened plaques on the artery wall. These plaques restrict...

2008-12-18 09:09:00

ROCKVILLE, Md., Dec. 18 /PRNewswire-FirstCall/ -- Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that GSK has initiated the first pivotal trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with chronic coronary heart disease. (Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO ) Darapladib was discovered by GSK based on HGS technology. HGS will receive 10% royalties on...

2008-09-24 09:00:13

SAN FRANCISCO, Sept. 24 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. , a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that it has completed the last patient visit in its Phase 2 acute coronary syndrome (ACS) study, including the sub-study of patients who received an additional 3 months of treatment followed by a multi-detector computed tomography (MDCT) scan. VIA will report top-line data from the ACS trial,...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related